Conavi Medical (CNVI) Price & Analysis

51 Followers

CNVI Stock Chart & Stats

C$0.42

Market closed

C$0.42

Day’s Range― - ―

52-Week RangeC$0.22 - C$0.70

Previous CloseN/A

VolumeN/A

Average Volume (3M)14.82K

Market Cap

C$20.06M

Enterprise ValueC$35.46M

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta0.26

Next Earnings

Aug 28, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.05

Shares Outstanding85,357,216

10 Day Avg. Volume15,374

30 Day Avg. Volume14,825

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)-0.12

Revenue Forecast (FY)C$4.19M

Bulls Say, Bears Say

Bulls Say

Product InnovationNovasight combines the two most common intravascular imaging modalities, which are crucial for guiding angioplasty and stenting of patients with coronary artery disease.

Regulatory ApprovalConavi is well-positioned to receive FDA clearance and launch its next generation Novasight Hybrid System.

Bears Say

Competitive RisksKey risks include competitive and balance sheet risks.

Conavi Medical News

Conavi Medical to Present at 2026 Bloom Burton Healthcare Investor Conference

Conavi Medical ( ($TSE:CNVI) ) has issued an announcement. Conavi Medical will showcase its cardiovascular imaging technology at...

3M ago

Conavi Medical Shareholders Back Board, Auditor and Expanded Equity Incentive Plan

An announcement from Conavi Medical ( ($TSE:CNVI) ) is now available. Conavi Medical reported the results of its...

3M ago

Conavi Medical Bolsters Balance Sheet as It Prepares U.S. Launch of Next-Gen Cardiac Imaging System

The latest announcement is out from Conavi Medical ( ($TSE:CNVI) ). Conavi Medical reported fiscal first-quarter 2026 revenue...

5M ago

Conavi Research Underscores Hybrid IVUS-OCT Edge as Next-Gen System Awaits FDA Review

An update from Conavi Medical ( ($TSE:CNVI) ) is now available. Conavi Medical highlighted new peer-reviewed research in...

5M ago

Conavi Medical Raises $12 Million to Advance U.S. Launch of Next-Generation Novasight System

Conavi Medical ( ($TSE:CNVI) ) has issued an update. Conavi Medical Corp. has closed a public equity offering...

6M ago

Conavi Medical Files Amended Prospectus for Up to $15 Million Equity Offering to Fund U.S. Novasight Launch

Conavi Medical ( ($TSE:CNVI) ) just unveiled an announcement. Conavi Medical Corp. has filed an amended and restated...

6M ago

Conavi Medical Advances Hybrid Intravascular Imaging Platform as Revenue Jumps in Fiscal 2025

An update from Conavi Medical ( ($TSE:CNVI) ) is now available. Conavi Medical reported that fiscal 2025 marked...

7M ago

Conavi Medical Prices Up to $20 Million Equity Offering to Fund U.S. Launch of Novasight Hybrid

An update from Conavi Medical ( ($TSE:CNVI) ) is now available. Conavi Medical Corp. has priced a public...

7M ago

CNVIF Earnings Report this Week: Is It a Buy, Ahead of Earnings?

Conavi Medical Corp. (CNVIF) is scheduled to report 4th quarter earnings on 12/18/2025. Regarding Q4 estimates, Wall Street...

7M ago

Conavi Medical Strengthens Leadership for U.S. Expansion

The latest announcement is out from Conavi Medical ( ($TSE:CNVI) ). Conavi Medical has announced strategic leadership changes...

8M ago

CNVI FAQ

What was Conavi Medical’s price range in the past 12 months?

Conavi Medical lowest stock price was C$0.21 and its highest was C$0.70 in the past 12 months.

What is Conavi Medical’s market cap?

Conavi Medical’s market cap is C$20.06M.

When is Conavi Medical’s upcoming earnings report date?

Conavi Medical’s upcoming earnings report date is Aug 28, 2026 which is in 46 days.

How were Conavi Medical’s earnings last quarter?

Conavi Medical released its earnings results on May 28, 2026. The company reported -C$0.051 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.051.

Is Conavi Medical overvalued?

According to Wall Street analysts Conavi Medical’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Conavi Medical pay dividends?

Conavi Medical does not currently pay dividends.

What is Conavi Medical’s EPS estimate?

Conavi Medical’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Conavi Medical have?

Conavi Medical has 85,357,216 shares outstanding.

What happened to Conavi Medical’s price movement after its last earnings report?

Conavi Medical reported an EPS of -C$0.051 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.818%.

Which hedge fund is a major shareholder of Conavi Medical?

Currently, no hedge funds are holding shares in TSE:CNVI

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Conavi Medical

Titan Medical, Inc. engages in the designing, development, and commercialization of new robotic surgical technologies. It focuses on developing Sport Surgical System, which is a single incision robotic surgical system that features multi-articulated instruments with single-use replaceable tips, and 3D display. The company was founded on July 28, 2008 and is headquartered in Toronto, Canada.